Perl Mario, Chung Chun-Shiang, Garber Megan, Huang Xin, Ayala Alfred
Division of Surgical Research, Department of Surgery, RI Hospital, Brown University School of Medicine, Providence, RI 02903, USA.
Front Biosci. 2006 Jan 1;11:272-99. doi: 10.2741/1797.
Sepsis is the leading cause of death in critically ill patients in the United States. It is associated with enormous expenditures within the health care system and despite substantial human, medical and fiscal resources directed at this clinical entity we have only had a modest effect on the septic patient's long-term survival. However, extensive studies over the last few decades have begun to reveal important pathophysiological processes around which a few promising therapeutic strategies with potential benefits may be derived. It is generally believed, that the body reacts to a septic challenge with an intense hyper-inflammatory response, designed to eliminate the underlying pathogen. However, along with and in response to the intense pro-inflammatory reaction, mechanisms fall into place to counter regulate (control) this initial response, typically resulting in a down regulation of the inflammatory response. This frequently results in dysfunction of various immunological conditions and may result in the inability to ward off the infection and consecutively lead to multiple organ dysfunction, multiple organ failure and death. It is the aberrant development of this anti-inflammatory/ immunosuppressive response, in which it is important to expand our understanding of pathological components to develop potential remedy. Upon this background this review aims to provide an overview on the pathophysiological mechanisms which initiate or maintain the down regulation of the immune response to a septic challenge and which might be a starting point for the development of therapeutic strategies.
脓毒症是美国重症患者的主要死因。它与医疗保健系统内的巨额支出相关,尽管针对这一临床实体投入了大量人力、医疗和财政资源,但我们对脓毒症患者的长期生存仅产生了有限的影响。然而,过去几十年的广泛研究已开始揭示重要的病理生理过程,从中或许可以得出一些具有潜在益处的、有前景的治疗策略。一般认为,机体对脓毒症挑战的反应是强烈的过度炎症反应,旨在清除潜在病原体。然而,伴随着强烈的促炎反应并作为对其的响应,机体启动了一些机制来对抗调节(控制)这一初始反应,通常会导致炎症反应下调。这经常导致各种免疫状况功能失调,并可能导致无法抵御感染,进而导致多器官功能障碍、多器官衰竭和死亡。正是这种抗炎/免疫抑制反应的异常发展,其中扩大对病理成分的理解对于开发潜在疗法至关重要。在此背景下,本综述旨在概述引发或维持对脓毒症挑战的免疫反应下调的病理生理机制,这些机制可能是治疗策略开发的起点。